Endocrinology

Researchers compared the effects of once-weekly semaglutide (2.4 mg) with a placebo during a 52-week period in patients with HFpEF and a BMI of 30 or higher.

Tirzepatide is now approved for a new indication. The dual GIP/GLP-1 agonist was previously approved for treating type 2 diabetes in May 2022.

The US Preventive Task Force (USPSTF) released its updated recommendations for screening children and adolescents for lipid disorders.

This COVID-19 roundup includes coverage on the FDA-approved oral antiviral treatment for adults with mild-to-moderate COVID-19, how antidepressant medication may lower the incidence of COVID-19, a study...

The FDA has approved empagliflozin, and empagliflozin and hydrochloride to help manage type 2 diabetes in pediatric patients.

Based on recent scientific knowledge, the American Diabetes Association (ADA) released a set of updates including recommendations for the detection and management of nonalcoholic fatty liver disease in...

Researchers evaluated the effectiveness of parathyroidectomy to manage kidney function in adults with hyperparathyroidism.

The researchers examined the mortality risks of bariatric surgery compared with patients who did not undergo surgery using 40-year follow-up.